nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—JAK2—ulcerative colitis	0.342	0.886	CbGaD
Sunitinib—ABCB1—ulcerative colitis	0.0438	0.114	CbGaD
Sunitinib—ABCC4—Mercaptopurine—ulcerative colitis	0.0296	0.166	CbGbCtD
Sunitinib—ABCC2—Sulfasalazine—ulcerative colitis	0.0144	0.0803	CbGbCtD
Sunitinib—ABCG2—Sulfasalazine—ulcerative colitis	0.013	0.0726	CbGbCtD
Sunitinib—ABCG2—Hydrocortisone—ulcerative colitis	0.0104	0.0583	CbGbCtD
Sunitinib—CYP3A4—Budesonide—ulcerative colitis	0.00829	0.0463	CbGbCtD
Sunitinib—CYP3A7—Hydrocortisone—ulcerative colitis	0.0077	0.043	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Hydrocortisone—ulcerative colitis	0.0077	0.043	CbGbCtD
Sunitinib—CYP3A5—Sulfasalazine—ulcerative colitis	0.00719	0.0402	CbGbCtD
Sunitinib—ABCC2—Dexamethasone—ulcerative colitis	0.00717	0.0401	CbGbCtD
Sunitinib—ABCG2—Dexamethasone—ulcerative colitis	0.00648	0.0362	CbGbCtD
Sunitinib—ABCB1—Methylprednisolone—ulcerative colitis	0.00618	0.0345	CbGbCtD
Sunitinib—CYP3A5—Hydrocortisone—ulcerative colitis	0.00577	0.0323	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Dexamethasone—ulcerative colitis	0.00479	0.0268	CbGbCtD
Sunitinib—CYP3A7—Dexamethasone—ulcerative colitis	0.00479	0.0268	CbGbCtD
Sunitinib—ABCB1—Betamethasone—ulcerative colitis	0.00402	0.0225	CbGbCtD
Sunitinib—ABCB1—Prednisolone—ulcerative colitis	0.00396	0.0222	CbGbCtD
Sunitinib—ABCB1—Hydrocortisone—ulcerative colitis	0.00376	0.021	CbGbCtD
Sunitinib—ABCB1—Prednisone—ulcerative colitis	0.00374	0.0209	CbGbCtD
Sunitinib—CYP3A4—Methylprednisolone—ulcerative colitis	0.0037	0.0207	CbGbCtD
Sunitinib—CYP3A4—Nicotine—ulcerative colitis	0.00361	0.0202	CbGbCtD
Sunitinib—CYP3A5—Dexamethasone—ulcerative colitis	0.00359	0.0201	CbGbCtD
Sunitinib—CYP3A4—Cholecalciferol—ulcerative colitis	0.00324	0.0181	CbGbCtD
Sunitinib—CYP3A4—Triamcinolone—ulcerative colitis	0.00281	0.0157	CbGbCtD
Sunitinib—CYP3A4—Betamethasone—ulcerative colitis	0.00241	0.0135	CbGbCtD
Sunitinib—CYP3A4—Prednisolone—ulcerative colitis	0.00237	0.0133	CbGbCtD
Sunitinib—ABCB1—Dexamethasone—ulcerative colitis	0.00234	0.0131	CbGbCtD
Sunitinib—CYP3A4—Hydrocortisone—ulcerative colitis	0.00225	0.0126	CbGbCtD
Sunitinib—CYP3A4—Prednisone—ulcerative colitis	0.00224	0.0125	CbGbCtD
Sunitinib—CYP3A4—Dexamethasone—ulcerative colitis	0.0014	0.00783	CbGbCtD
Sunitinib—Procainamide—SLC22A4—ulcerative colitis	0.00126	0.571	CrCbGaD
Sunitinib—Procainamide—SLC22A5—ulcerative colitis	0.000946	0.429	CrCbGaD
Sunitinib—STK17B—lymphoid tissue—ulcerative colitis	0.000713	0.0069	CbGeAlD
Sunitinib—TLK2—liver—ulcerative colitis	0.000669	0.00647	CbGeAlD
Sunitinib—STK17A—lymphoid tissue—ulcerative colitis	0.000657	0.00636	CbGeAlD
Sunitinib—NUAK1—smooth muscle tissue—ulcerative colitis	0.000653	0.00632	CbGeAlD
Sunitinib—STK17A—digestive system—ulcerative colitis	0.000649	0.00628	CbGeAlD
Sunitinib—STK38—smooth muscle tissue—ulcerative colitis	0.000637	0.00617	CbGeAlD
Sunitinib—RPS6KA2—smooth muscle tissue—ulcerative colitis	0.000637	0.00617	CbGeAlD
Sunitinib—CDK16—digestive system—ulcerative colitis	0.000631	0.0061	CbGeAlD
Sunitinib—CSNK1G2—smooth muscle tissue—ulcerative colitis	0.000628	0.00607	CbGeAlD
Sunitinib—PKN1—smooth muscle tissue—ulcerative colitis	0.000628	0.00607	CbGeAlD
Sunitinib—STK33—digestive system—ulcerative colitis	0.000622	0.00602	CbGeAlD
Sunitinib—MYLK—epithelium—ulcerative colitis	0.000608	0.00588	CbGeAlD
Sunitinib—CLK4—lymphoid tissue—ulcerative colitis	0.000606	0.00587	CbGeAlD
Sunitinib—ITK—lymphoid tissue—ulcerative colitis	0.000599	0.0058	CbGeAlD
Sunitinib—CSNK2A1—smooth muscle tissue—ulcerative colitis	0.000593	0.00574	CbGeAlD
Sunitinib—BLK—lymphoid tissue—ulcerative colitis	0.000592	0.00573	CbGeAlD
Sunitinib—MYLK—smooth muscle tissue—ulcerative colitis	0.000586	0.00567	CbGeAlD
Sunitinib—DAPK1—lymphoid tissue—ulcerative colitis	0.000586	0.00567	CbGeAlD
Sunitinib—DAPK1—digestive system—ulcerative colitis	0.000578	0.0056	CbGeAlD
Sunitinib—STK11—lymphoid tissue—ulcerative colitis	0.000567	0.00549	CbGeAlD
Sunitinib—BRD4—lymphoid tissue—ulcerative colitis	0.000567	0.00549	CbGeAlD
Sunitinib—BRD4—digestive system—ulcerative colitis	0.00056	0.00542	CbGeAlD
Sunitinib—STK11—digestive system—ulcerative colitis	0.00056	0.00542	CbGeAlD
Sunitinib—ERN1—liver—ulcerative colitis	0.000545	0.00527	CbGeAlD
Sunitinib—MARK2—digestive system—ulcerative colitis	0.000544	0.00526	CbGeAlD
Sunitinib—PRPF4—Calcitriol—Cholecalciferol—ulcerative colitis	0.000527	0.169	CbGdCrCtD
Sunitinib—STK17B—liver—ulcerative colitis	0.000525	0.00508	CbGeAlD
Sunitinib—DAPK3—smooth muscle tissue—ulcerative colitis	0.000522	0.00505	CbGeAlD
Sunitinib—ROCK1—epithelium—ulcerative colitis	0.00052	0.00503	CbGeAlD
Sunitinib—INSR—lymphoid tissue—ulcerative colitis	0.000518	0.00501	CbGeAlD
Sunitinib—SNRK—lymphoid tissue—ulcerative colitis	0.000518	0.00501	CbGeAlD
Sunitinib—INSR—digestive system—ulcerative colitis	0.000511	0.00495	CbGeAlD
Sunitinib—STK38—lymphoid tissue—ulcerative colitis	0.000509	0.00493	CbGeAlD
Sunitinib—RPS6KA2—lymphoid tissue—ulcerative colitis	0.000509	0.00493	CbGeAlD
Sunitinib—STK38—digestive system—ulcerative colitis	0.000503	0.00487	CbGeAlD
Sunitinib—CSNK1G2—lymphoid tissue—ulcerative colitis	0.000502	0.00485	CbGeAlD
Sunitinib—PKN1—lymphoid tissue—ulcerative colitis	0.000502	0.00485	CbGeAlD
Sunitinib—ROCK1—smooth muscle tissue—ulcerative colitis	0.000501	0.00485	CbGeAlD
Sunitinib—PKN1—digestive system—ulcerative colitis	0.000496	0.00479	CbGeAlD
Sunitinib—CSNK1G2—digestive system—ulcerative colitis	0.000496	0.00479	CbGeAlD
Sunitinib—PRPF4—lymphoid tissue—ulcerative colitis	0.000494	0.00478	CbGeAlD
Sunitinib—PRPF4—digestive system—ulcerative colitis	0.000488	0.00472	CbGeAlD
Sunitinib—PRPF4B—lymphoid tissue—ulcerative colitis	0.000487	0.00471	CbGeAlD
Sunitinib—STK17A—liver—ulcerative colitis	0.000484	0.00468	CbGeAlD
Sunitinib—PRPF4B—digestive system—ulcerative colitis	0.000481	0.00466	CbGeAlD
Sunitinib—CDK14—liver—ulcerative colitis	0.000477	0.00461	CbGeAlD
Sunitinib—CDK16—liver—ulcerative colitis	0.00047	0.00455	CbGeAlD
Sunitinib—LATS2—liver—ulcerative colitis	0.00047	0.00455	CbGeAlD
Sunitinib—MAP2K1—epithelium—ulcerative colitis	0.00047	0.00454	CbGeAlD
Sunitinib—MAP4K4—smooth muscle tissue—ulcerative colitis	0.000469	0.00453	CbGeAlD
Sunitinib—CSNK2A1—digestive system—ulcerative colitis	0.000468	0.00453	CbGeAlD
Sunitinib—MYLK—lymphoid tissue—ulcerative colitis	0.000468	0.00453	CbGeAlD
Sunitinib—MYLK—digestive system—ulcerative colitis	0.000462	0.00447	CbGeAlD
Sunitinib—PLK4—lymphoid tissue—ulcerative colitis	0.000462	0.00447	CbGeAlD
Sunitinib—STK4—lymphoid tissue—ulcerative colitis	0.00046	0.00445	CbGeAlD
Sunitinib—STK4—digestive system—ulcerative colitis	0.000454	0.00439	CbGeAlD
Sunitinib—MAP2K1—smooth muscle tissue—ulcerative colitis	0.000453	0.00438	CbGeAlD
Sunitinib—CSNK1A1—smooth muscle tissue—ulcerative colitis	0.000447	0.00432	CbGeAlD
Sunitinib—CLK4—liver—ulcerative colitis	0.000446	0.00432	CbGeAlD
Sunitinib—STK16—lymphoid tissue—ulcerative colitis	0.000437	0.00422	CbGeAlD
Sunitinib—FLT4—epithelium—ulcerative colitis	0.000435	0.00421	CbGeAlD
Sunitinib—HIPK2—lymphoid tissue—ulcerative colitis	0.000434	0.0042	CbGeAlD
Sunitinib—TYRO3—lymphoid tissue—ulcerative colitis	0.000434	0.0042	CbGeAlD
Sunitinib—ALK—lymphoid tissue—ulcerative colitis	0.000434	0.0042	CbGeAlD
Sunitinib—STK16—digestive system—ulcerative colitis	0.000431	0.00417	CbGeAlD
Sunitinib—DAPK1—liver—ulcerative colitis	0.000431	0.00417	CbGeAlD
Sunitinib—OXSR1—Methyldopa—Mesalazine—ulcerative colitis	0.000431	0.138	CbGdCrCtD
Sunitinib—HIPK2—digestive system—ulcerative colitis	0.000429	0.00415	CbGeAlD
Sunitinib—HIPK3—digestive system—ulcerative colitis	0.000429	0.00415	CbGeAlD
Sunitinib—ALK—digestive system—ulcerative colitis	0.000429	0.00415	CbGeAlD
Sunitinib—MAP4K1—lymphoid tissue—ulcerative colitis	0.000425	0.00412	CbGeAlD
Sunitinib—PTK2B—smooth muscle tissue—ulcerative colitis	0.000421	0.00407	CbGeAlD
Sunitinib—BRD4—liver—ulcerative colitis	0.000417	0.00404	CbGeAlD
Sunitinib—STK11—liver—ulcerative colitis	0.000417	0.00404	CbGeAlD
Sunitinib—CLK2—lymphoid tissue—ulcerative colitis	0.000413	0.004	CbGeAlD
Sunitinib—RIOK1—liver—ulcerative colitis	0.000413	0.004	CbGeAlD
Sunitinib—RPS6KA1—liver—ulcerative colitis	0.000413	0.004	CbGeAlD
Sunitinib—MAP4K2—lymphoid tissue—ulcerative colitis	0.000411	0.00398	CbGeAlD
Sunitinib—TNIK—liver—ulcerative colitis	0.000405	0.00392	CbGeAlD
Sunitinib—SGK3—liver—ulcerative colitis	0.000401	0.00388	CbGeAlD
Sunitinib—ROCK1—lymphoid tissue—ulcerative colitis	0.000401	0.00388	CbGeAlD
Sunitinib—MAP2K2—smooth muscle tissue—ulcerative colitis	0.000398	0.00386	CbGeAlD
Sunitinib—ICK—liver—ulcerative colitis	0.000398	0.00385	CbGeAlD
Sunitinib—ROCK1—digestive system—ulcerative colitis	0.000396	0.00383	CbGeAlD
Sunitinib—MAP3K7—smooth muscle tissue—ulcerative colitis	0.000392	0.00379	CbGeAlD
Sunitinib—DYRK1A—lymphoid tissue—ulcerative colitis	0.000391	0.00378	CbGeAlD
Sunitinib—RPS6KB1—epithelium—ulcerative colitis	0.000387	0.00374	CbGeAlD
Sunitinib—TYK2—smooth muscle tissue—ulcerative colitis	0.000385	0.00372	CbGeAlD
Sunitinib—RET—epithelium—ulcerative colitis	0.000384	0.00372	CbGeAlD
Sunitinib—NUAK1—liver—ulcerative colitis	0.000384	0.00372	CbGeAlD
Sunitinib—MERTK—lymphoid tissue—ulcerative colitis	0.000382	0.00369	CbGeAlD
Sunitinib—OXSR1—liver—ulcerative colitis	0.000381	0.00369	CbGeAlD
Sunitinib—SNRK—liver—ulcerative colitis	0.000381	0.00369	CbGeAlD
Sunitinib—INSR—liver—ulcerative colitis	0.000381	0.00369	CbGeAlD
Sunitinib—IRAK1—smooth muscle tissue—ulcerative colitis	0.00038	0.00367	CbGeAlD
Sunitinib—RPS6KA2—liver—ulcerative colitis	0.000375	0.00363	CbGeAlD
Sunitinib—STK38—liver—ulcerative colitis	0.000375	0.00363	CbGeAlD
Sunitinib—MAP4K4—lymphoid tissue—ulcerative colitis	0.000375	0.00362	CbGeAlD
Sunitinib—RPS6KB1—smooth muscle tissue—ulcerative colitis	0.000373	0.00361	CbGeAlD
Sunitinib—MAP4K4—digestive system—ulcerative colitis	0.00037	0.00358	CbGeAlD
Sunitinib—FLT3—lymphoid tissue—ulcerative colitis	0.000369	0.00357	CbGeAlD
Sunitinib—PKN1—liver—ulcerative colitis	0.000369	0.00357	CbGeAlD
Sunitinib—CSNK1G2—liver—ulcerative colitis	0.000369	0.00357	CbGeAlD
Sunitinib—AXL—smooth muscle tissue—ulcerative colitis	0.000369	0.00357	CbGeAlD
Sunitinib—FGFR2—epithelium—ulcerative colitis	0.000365	0.00353	CbGeAlD
Sunitinib—RPS6KA3—lymphoid tissue—ulcerative colitis	0.000364	0.00352	CbGeAlD
Sunitinib—PRPF4—liver—ulcerative colitis	0.000364	0.00352	CbGeAlD
Sunitinib—JAK2—epithelium—ulcerative colitis	0.000363	0.00352	CbGeAlD
Sunitinib—MAP2K1—lymphoid tissue—ulcerative colitis	0.000362	0.0035	CbGeAlD
Sunitinib—PRPF4B—liver—ulcerative colitis	0.000359	0.00347	CbGeAlD
Sunitinib—MAP2K1—digestive system—ulcerative colitis	0.000357	0.00346	CbGeAlD
Sunitinib—CSNK1A1—lymphoid tissue—ulcerative colitis	0.000357	0.00345	CbGeAlD
Sunitinib—CLK1—lymphoid tissue—ulcerative colitis	0.000355	0.00343	CbGeAlD
Sunitinib—CSNK1A1—digestive system—ulcerative colitis	0.000353	0.00341	CbGeAlD
Sunitinib—FGFR2—smooth muscle tissue—ulcerative colitis	0.000352	0.00341	CbGeAlD
Sunitinib—CLK1—digestive system—ulcerative colitis	0.00035	0.00339	CbGeAlD
Sunitinib—JAK2—smooth muscle tissue—ulcerative colitis	0.00035	0.00339	CbGeAlD
Sunitinib—CSNK2A1—liver—ulcerative colitis	0.000349	0.00338	CbGeAlD
Sunitinib—FYN—smooth muscle tissue—ulcerative colitis	0.000345	0.00334	CbGeAlD
Sunitinib—MYLK—liver—ulcerative colitis	0.000345	0.00333	CbGeAlD
Sunitinib—CAMK2G—digestive system—ulcerative colitis	0.000344	0.00333	CbGeAlD
Sunitinib—PRKAA1—lymphoid tissue—ulcerative colitis	0.00034	0.00329	CbGeAlD
Sunitinib—FLT1—epithelium—ulcerative colitis	0.000339	0.00328	CbGeAlD
Sunitinib—STK4—liver—ulcerative colitis	0.000338	0.00327	CbGeAlD
Sunitinib—MAP4K5—smooth muscle tissue—ulcerative colitis	0.000337	0.00326	CbGeAlD
Sunitinib—PTK2B—lymphoid tissue—ulcerative colitis	0.000336	0.00325	CbGeAlD
Sunitinib—PRKAA1—digestive system—ulcerative colitis	0.000336	0.00325	CbGeAlD
Sunitinib—FLT4—lymphoid tissue—ulcerative colitis	0.000335	0.00324	CbGeAlD
Sunitinib—PTK2B—digestive system—ulcerative colitis	0.000332	0.00321	CbGeAlD
Sunitinib—PHKG2—liver—ulcerative colitis	0.000332	0.00321	CbGeAlD
Sunitinib—STK24—liver—ulcerative colitis	0.00033	0.0032	CbGeAlD
Sunitinib—CSNK1E—digestive system—ulcerative colitis	0.000327	0.00316	CbGeAlD
Sunitinib—FLT1—smooth muscle tissue—ulcerative colitis	0.000326	0.00316	CbGeAlD
Sunitinib—IRAK4—lymphoid tissue—ulcerative colitis	0.000326	0.00315	CbGeAlD
Sunitinib—STK16—liver—ulcerative colitis	0.000321	0.00311	CbGeAlD
Sunitinib—HIPK3—liver—ulcerative colitis	0.00032	0.00309	CbGeAlD
Sunitinib—HIPK2—liver—ulcerative colitis	0.00032	0.00309	CbGeAlD
Sunitinib—MAP2K2—lymphoid tissue—ulcerative colitis	0.000319	0.00308	CbGeAlD
Sunitinib—TNK1—liver—ulcerative colitis	0.000316	0.00306	CbGeAlD
Sunitinib—RIOK2—liver—ulcerative colitis	0.000316	0.00306	CbGeAlD
Sunitinib—MAP3K2—lymphoid tissue—ulcerative colitis	0.000316	0.00306	CbGeAlD
Sunitinib—MAP2K2—digestive system—ulcerative colitis	0.000315	0.00304	CbGeAlD
Sunitinib—ULK3—digestive system—ulcerative colitis	0.000315	0.00304	CbGeAlD
Sunitinib—YES1—smooth muscle tissue—ulcerative colitis	0.000312	0.00302	CbGeAlD
Sunitinib—TBK1—lymphoid tissue—ulcerative colitis	0.00031	0.003	CbGeAlD
Sunitinib—TYK2—lymphoid tissue—ulcerative colitis	0.000308	0.00298	CbGeAlD
Sunitinib—DAPK3—liver—ulcerative colitis	0.000307	0.00297	CbGeAlD
Sunitinib—TBK1—digestive system—ulcerative colitis	0.000306	0.00296	CbGeAlD
Sunitinib—PDGFRA—smooth muscle tissue—ulcerative colitis	0.000306	0.00296	CbGeAlD
Sunitinib—CLK2—liver—ulcerative colitis	0.000304	0.00294	CbGeAlD
Sunitinib—TYK2—digestive system—ulcerative colitis	0.000304	0.00294	CbGeAlD
Sunitinib—MAP4K2—liver—ulcerative colitis	0.000303	0.00293	CbGeAlD
Sunitinib—STK3—liver—ulcerative colitis	0.000299	0.00289	CbGeAlD
Sunitinib—RPS6KB1—lymphoid tissue—ulcerative colitis	0.000298	0.00288	CbGeAlD
Sunitinib—FGR—lymphoid tissue—ulcerative colitis	0.000296	0.00286	CbGeAlD
Sunitinib—RET—lymphoid tissue—ulcerative colitis	0.000296	0.00286	CbGeAlD
Sunitinib—AXL—lymphoid tissue—ulcerative colitis	0.000295	0.00285	CbGeAlD
Sunitinib—ROCK1—liver—ulcerative colitis	0.000295	0.00285	CbGeAlD
Sunitinib—RPS6KB1—digestive system—ulcerative colitis	0.000294	0.00285	CbGeAlD
Sunitinib—RET—digestive system—ulcerative colitis	0.000292	0.00283	CbGeAlD
Sunitinib—FGR—digestive system—ulcerative colitis	0.000292	0.00283	CbGeAlD
Sunitinib—DYRK1A—liver—ulcerative colitis	0.000288	0.00278	CbGeAlD
Sunitinib—KDR—epithelium—ulcerative colitis	0.000286	0.00277	CbGeAlD
Sunitinib—MERTK—liver—ulcerative colitis	0.000281	0.00272	CbGeAlD
Sunitinib—JAK2—lymphoid tissue—ulcerative colitis	0.00028	0.00271	CbGeAlD
Sunitinib—FGFR2—digestive system—ulcerative colitis	0.000278	0.00269	CbGeAlD
Sunitinib—JAK2—digestive system—ulcerative colitis	0.000276	0.00267	CbGeAlD
Sunitinib—FYN—lymphoid tissue—ulcerative colitis	0.000276	0.00267	CbGeAlD
Sunitinib—KDR—smooth muscle tissue—ulcerative colitis	0.000276	0.00267	CbGeAlD
Sunitinib—MAP4K4—liver—ulcerative colitis	0.000276	0.00267	CbGeAlD
Sunitinib—NUAK2—liver—ulcerative colitis	0.000274	0.00265	CbGeAlD
Sunitinib—FYN—digestive system—ulcerative colitis	0.000273	0.00264	CbGeAlD
Sunitinib—FLT3—liver—ulcerative colitis	0.000272	0.00263	CbGeAlD
Sunitinib—MAP3K12—liver—ulcerative colitis	0.000272	0.00263	CbGeAlD
Sunitinib—MAP4K5—lymphoid tissue—ulcerative colitis	0.00027	0.00261	CbGeAlD
Sunitinib—CSF1R—smooth muscle tissue—ulcerative colitis	0.000269	0.0026	CbGeAlD
Sunitinib—RPS6KA3—liver—ulcerative colitis	0.000268	0.00259	CbGeAlD
Sunitinib—TLK2—Progesterone—Hydrocortisone—ulcerative colitis	0.000267	0.0855	CbGdCrCtD
Sunitinib—MAP2K1—liver—ulcerative colitis	0.000266	0.00258	CbGeAlD
Sunitinib—CSNK1A1—liver—ulcerative colitis	0.000263	0.00254	CbGeAlD
Sunitinib—CLK1—liver—ulcerative colitis	0.000261	0.00253	CbGeAlD
Sunitinib—FLT1—lymphoid tissue—ulcerative colitis	0.000261	0.00252	CbGeAlD
Sunitinib—FLT1—digestive system—ulcerative colitis	0.000258	0.00249	CbGeAlD
Sunitinib—CAMK2G—liver—ulcerative colitis	0.000256	0.00248	CbGeAlD
Sunitinib—BMP2K—liver—ulcerative colitis	0.000256	0.00248	CbGeAlD
Sunitinib—LRRK2—liver—ulcerative colitis	0.000254	0.00246	CbGeAlD
Sunitinib—KIT—epithelium—ulcerative colitis	0.000254	0.00245	CbGeAlD
Sunitinib—PRKAA1—liver—ulcerative colitis	0.00025	0.00242	CbGeAlD
Sunitinib—YES1—lymphoid tissue—ulcerative colitis	0.000249	0.00241	CbGeAlD
Sunitinib—PDGFRB—epithelium—ulcerative colitis	0.000248	0.0024	CbGeAlD
Sunitinib—PTK2B—liver—ulcerative colitis	0.000248	0.00239	CbGeAlD
Sunitinib—STK10—lymphoid tissue—ulcerative colitis	0.000247	0.00239	CbGeAlD
Sunitinib—FLT4—liver—ulcerative colitis	0.000247	0.00239	CbGeAlD
Sunitinib—YES1—digestive system—ulcerative colitis	0.000246	0.00238	CbGeAlD
Sunitinib—TAOK3—lymphoid tissue—ulcerative colitis	0.000246	0.00238	CbGeAlD
Sunitinib—KIT—smooth muscle tissue—ulcerative colitis	0.000244	0.00236	CbGeAlD
Sunitinib—PDGFRA—lymphoid tissue—ulcerative colitis	0.000244	0.00236	CbGeAlD
Sunitinib—STK10—digestive system—ulcerative colitis	0.000244	0.00236	CbGeAlD
Sunitinib—FGFR1—liver—ulcerative colitis	0.000244	0.00236	CbGeAlD
Sunitinib—CSNK1E—liver—ulcerative colitis	0.000244	0.00236	CbGeAlD
Sunitinib—TAOK3—digestive system—ulcerative colitis	0.000243	0.00235	CbGeAlD
Sunitinib—PDGFRA—digestive system—ulcerative colitis	0.000241	0.00234	CbGeAlD
Sunitinib—IRAK4—liver—ulcerative colitis	0.00024	0.00232	CbGeAlD
Sunitinib—PRPF4—Methyldopa—Mesalazine—ulcerative colitis	0.00024	0.0766	CbGdCrCtD
Sunitinib—PDGFRB—smooth muscle tissue—ulcerative colitis	0.000239	0.00231	CbGeAlD
Sunitinib—ULK3—liver—ulcerative colitis	0.000234	0.00227	CbGeAlD
Sunitinib—MAP2K2—liver—ulcerative colitis	0.000234	0.00227	CbGeAlD
Sunitinib—MAP3K2—liver—ulcerative colitis	0.000233	0.00225	CbGeAlD
Sunitinib—MAP3K7—liver—ulcerative colitis	0.000231	0.00223	CbGeAlD
Sunitinib—TBK1—liver—ulcerative colitis	0.000228	0.0022	CbGeAlD
Sunitinib—TYK2—liver—ulcerative colitis	0.000226	0.00219	CbGeAlD
Sunitinib—TLK2—Progesterone—Prednisolone—ulcerative colitis	0.000225	0.0718	CbGdCrCtD
Sunitinib—IRAK1—liver—ulcerative colitis	0.000223	0.00216	CbGeAlD
Sunitinib—KDR—lymphoid tissue—ulcerative colitis	0.00022	0.00213	CbGeAlD
Sunitinib—RPS6KB1—liver—ulcerative colitis	0.000219	0.00212	CbGeAlD
Sunitinib—FGR—liver—ulcerative colitis	0.000218	0.00211	CbGeAlD
Sunitinib—KDR—digestive system—ulcerative colitis	0.000218	0.00211	CbGeAlD
Sunitinib—AXL—liver—ulcerative colitis	0.000217	0.0021	CbGeAlD
Sunitinib—CSF1R—lymphoid tissue—ulcerative colitis	0.000215	0.00208	CbGeAlD
Sunitinib—CSF1R—digestive system—ulcerative colitis	0.000213	0.00206	CbGeAlD
Sunitinib—SLK—liver—ulcerative colitis	0.000209	0.00202	CbGeAlD
Sunitinib—CYP3A7—liver—ulcerative colitis	0.000208	0.00201	CbGeAlD
Sunitinib—FGFR2—liver—ulcerative colitis	0.000207	0.002	CbGeAlD
Sunitinib—JAK2—liver—ulcerative colitis	0.000206	0.00199	CbGeAlD
Sunitinib—FYN—liver—ulcerative colitis	0.000203	0.00197	CbGeAlD
Sunitinib—MAP4K5—liver—ulcerative colitis	0.000199	0.00192	CbGeAlD
Sunitinib—MAP3K3—liver—ulcerative colitis	0.000199	0.00192	CbGeAlD
Sunitinib—KIT—lymphoid tissue—ulcerative colitis	0.000195	0.00189	CbGeAlD
Sunitinib—KIT—digestive system—ulcerative colitis	0.000193	0.00187	CbGeAlD
Sunitinib—FLT1—liver—ulcerative colitis	0.000192	0.00186	CbGeAlD
Sunitinib—PDGFRB—lymphoid tissue—ulcerative colitis	0.000191	0.00185	CbGeAlD
Sunitinib—PDGFRB—digestive system—ulcerative colitis	0.000188	0.00182	CbGeAlD
Sunitinib—MAP4K4—Testosterone Propionate—Hydrocortisone—ulcerative colitis	0.000184	0.0589	CbGdCrCtD
Sunitinib—YES1—liver—ulcerative colitis	0.000183	0.00177	CbGeAlD
Sunitinib—STK10—liver—ulcerative colitis	0.000182	0.00176	CbGeAlD
Sunitinib—TAOK3—liver—ulcerative colitis	0.000181	0.00175	CbGeAlD
Sunitinib—PDGFRA—liver—ulcerative colitis	0.00018	0.00174	CbGeAlD
Sunitinib—CYP3A7-CYP3A51P—liver—ulcerative colitis	0.000177	0.00171	CbGeAlD
Sunitinib—KDR—liver—ulcerative colitis	0.000162	0.00157	CbGeAlD
Sunitinib—MAP2K5—liver—ulcerative colitis	0.000162	0.00157	CbGeAlD
Sunitinib—CSF1R—liver—ulcerative colitis	0.000158	0.00153	CbGeAlD
Sunitinib—ABCC4—digestive system—ulcerative colitis	0.00015	0.00145	CbGeAlD
Sunitinib—ABCC2—digestive system—ulcerative colitis	0.000145	0.00141	CbGeAlD
Sunitinib—KIT—liver—ulcerative colitis	0.000144	0.00139	CbGeAlD
Sunitinib—PDGFRB—liver—ulcerative colitis	0.00014	0.00136	CbGeAlD
Sunitinib—ABCC4—liver—ulcerative colitis	0.000112	0.00108	CbGeAlD
Sunitinib—ABCC2—liver—ulcerative colitis	0.000108	0.00105	CbGeAlD
Sunitinib—CSNK1E—Dexamethasone—Budesonide—ulcerative colitis	0.000105	0.0335	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Budesonide—ulcerative colitis	0.000105	0.0335	CbGdCrCtD
Sunitinib—CYP3A5—digestive system—ulcerative colitis	9.83e-05	0.000951	CbGeAlD
Sunitinib—CSNK1E—Danazol—Hydrocortisone—ulcerative colitis	8.4e-05	0.0268	CbGdCrCtD
Sunitinib—ABCG2—liver—ulcerative colitis	7.89e-05	0.000764	CbGeAlD
Sunitinib—CYP3A4—digestive system—ulcerative colitis	7.38e-05	0.000714	CbGeAlD
Sunitinib—CYP3A5—liver—ulcerative colitis	7.33e-05	0.000709	CbGeAlD
Sunitinib—CSNK1E—Danazol—Prednisone—ulcerative colitis	7.23e-05	0.0231	CbGdCrCtD
Sunitinib—ABCB1—epithelium—ulcerative colitis	6.87e-05	0.000664	CbGeAlD
Sunitinib—Mental disorder—Methylprednisolone—ulcerative colitis	6.82e-05	0.000482	CcSEcCtD
Sunitinib—Erythema—Triamcinolone—ulcerative colitis	6.79e-05	0.00048	CcSEcCtD
Sunitinib—Erythema—Methylprednisolone—ulcerative colitis	6.77e-05	0.000479	CcSEcCtD
Sunitinib—Malnutrition—Methylprednisolone—ulcerative colitis	6.77e-05	0.000479	CcSEcCtD
Sunitinib—Acute coronary syndrome—Prednisone—ulcerative colitis	6.77e-05	0.000478	CcSEcCtD
Sunitinib—Gastrointestinal pain—Mesalazine—ulcerative colitis	6.77e-05	0.000478	CcSEcCtD
Sunitinib—Angioedema—Prednisolone—ulcerative colitis	6.75e-05	0.000477	CcSEcCtD
Sunitinib—Neuropathy peripheral—Prednisone—ulcerative colitis	6.73e-05	0.000476	CcSEcCtD
Sunitinib—Dizziness—Budesonide—ulcerative colitis	6.73e-05	0.000476	CcSEcCtD
Sunitinib—Hypersensitivity—Azathioprine—ulcerative colitis	6.69e-05	0.000473	CcSEcCtD
Sunitinib—Dysgeusia—Triamcinolone—ulcerative colitis	6.65e-05	0.00047	CcSEcCtD
Sunitinib—Eye disorder—Dexamethasone—ulcerative colitis	6.61e-05	0.000468	CcSEcCtD
Sunitinib—Eye disorder—Betamethasone—ulcerative colitis	6.61e-05	0.000468	CcSEcCtD
Sunitinib—Angioedema—Hydrocortisone—ulcerative colitis	6.59e-05	0.000466	CcSEcCtD
Sunitinib—Back pain—Triamcinolone—ulcerative colitis	6.57e-05	0.000464	CcSEcCtD
Sunitinib—Body temperature increased—Mesalazine—ulcerative colitis	6.54e-05	0.000462	CcSEcCtD
Sunitinib—Abdominal pain—Mesalazine—ulcerative colitis	6.54e-05	0.000462	CcSEcCtD
Sunitinib—Vomiting—Budesonide—ulcerative colitis	6.47e-05	0.000457	CcSEcCtD
Sunitinib—Angiopathy—Betamethasone—ulcerative colitis	6.42e-05	0.000454	CcSEcCtD
Sunitinib—Angiopathy—Dexamethasone—ulcerative colitis	6.42e-05	0.000454	CcSEcCtD
Sunitinib—Rash—Budesonide—ulcerative colitis	6.42e-05	0.000454	CcSEcCtD
Sunitinib—Dermatitis—Budesonide—ulcerative colitis	6.41e-05	0.000453	CcSEcCtD
Sunitinib—Convulsion—Prednisolone—ulcerative colitis	6.4e-05	0.000452	CcSEcCtD
Sunitinib—Headache—Budesonide—ulcerative colitis	6.38e-05	0.000451	CcSEcCtD
Sunitinib—Hypertension—Prednisolone—ulcerative colitis	6.37e-05	0.000451	CcSEcCtD
Sunitinib—Arrhythmia—Betamethasone—ulcerative colitis	6.32e-05	0.000447	CcSEcCtD
Sunitinib—Arrhythmia—Dexamethasone—ulcerative colitis	6.32e-05	0.000447	CcSEcCtD
Sunitinib—Bradycardia—Prednisone—ulcerative colitis	6.27e-05	0.000444	CcSEcCtD
Sunitinib—Alopecia—Betamethasone—ulcerative colitis	6.25e-05	0.000442	CcSEcCtD
Sunitinib—Alopecia—Dexamethasone—ulcerative colitis	6.25e-05	0.000442	CcSEcCtD
Sunitinib—Convulsion—Hydrocortisone—ulcerative colitis	6.25e-05	0.000442	CcSEcCtD
Sunitinib—Hypertension—Hydrocortisone—ulcerative colitis	6.23e-05	0.00044	CcSEcCtD
Sunitinib—Diarrhoea—Azathioprine—ulcerative colitis	6.22e-05	0.000439	CcSEcCtD
Sunitinib—Angioedema—Triamcinolone—ulcerative colitis	6.2e-05	0.000439	CcSEcCtD
Sunitinib—Haemoglobin—Prednisone—ulcerative colitis	6.19e-05	0.000438	CcSEcCtD
Sunitinib—Angioedema—Methylprednisolone—ulcerative colitis	6.19e-05	0.000438	CcSEcCtD
Sunitinib—Haemorrhage—Prednisone—ulcerative colitis	6.16e-05	0.000436	CcSEcCtD
Sunitinib—Erythema—Dexamethasone—ulcerative colitis	6.16e-05	0.000436	CcSEcCtD
Sunitinib—Erythema—Betamethasone—ulcerative colitis	6.16e-05	0.000436	CcSEcCtD
Sunitinib—Myalgia—Hydrocortisone—ulcerative colitis	6.14e-05	0.000434	CcSEcCtD
Sunitinib—Hypersensitivity—Mesalazine—ulcerative colitis	6.1e-05	0.000431	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	6.1e-05	0.000431	CcSEcCtD
Sunitinib—Connective tissue disorder—Prednisone—ulcerative colitis	6.06e-05	0.000428	CcSEcCtD
Sunitinib—Nausea—Budesonide—ulcerative colitis	6.04e-05	0.000427	CcSEcCtD
Sunitinib—Oedema—Prednisolone—ulcerative colitis	6.03e-05	0.000426	CcSEcCtD
Sunitinib—Dizziness—Azathioprine—ulcerative colitis	6.01e-05	0.000425	CcSEcCtD
Sunitinib—Asthenia—Mesalazine—ulcerative colitis	5.94e-05	0.00042	CcSEcCtD
Sunitinib—Shock—Prednisolone—ulcerative colitis	5.93e-05	0.000419	CcSEcCtD
Sunitinib—Cough—Triamcinolone—ulcerative colitis	5.93e-05	0.000419	CcSEcCtD
Sunitinib—Oedema—Hydrocortisone—ulcerative colitis	5.89e-05	0.000416	CcSEcCtD
Sunitinib—Convulsion—Triamcinolone—ulcerative colitis	5.88e-05	0.000416	CcSEcCtD
Sunitinib—Convulsion—Methylprednisolone—ulcerative colitis	5.87e-05	0.000415	CcSEcCtD
Sunitinib—Hypertension—Triamcinolone—ulcerative colitis	5.86e-05	0.000414	CcSEcCtD
Sunitinib—Pruritus—Mesalazine—ulcerative colitis	5.86e-05	0.000414	CcSEcCtD
Sunitinib—Hypertension—Methylprednisolone—ulcerative colitis	5.85e-05	0.000413	CcSEcCtD
Sunitinib—Infection—Hydrocortisone—ulcerative colitis	5.85e-05	0.000413	CcSEcCtD
Sunitinib—Shock—Hydrocortisone—ulcerative colitis	5.79e-05	0.000409	CcSEcCtD
Sunitinib—Myalgia—Triamcinolone—ulcerative colitis	5.78e-05	0.000409	CcSEcCtD
Sunitinib—Vomiting—Azathioprine—ulcerative colitis	5.78e-05	0.000408	CcSEcCtD
Sunitinib—Nervous system disorder—Hydrocortisone—ulcerative colitis	5.77e-05	0.000408	CcSEcCtD
Sunitinib—Arthralgia—Methylprednisolone—ulcerative colitis	5.77e-05	0.000408	CcSEcCtD
Sunitinib—Myalgia—Methylprednisolone—ulcerative colitis	5.77e-05	0.000408	CcSEcCtD
Sunitinib—Eye disorder—Prednisone—ulcerative colitis	5.76e-05	0.000407	CcSEcCtD
Sunitinib—Rash—Azathioprine—ulcerative colitis	5.73e-05	0.000405	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	5.73e-05	0.000405	CcSEcCtD
Sunitinib—Dermatitis—Azathioprine—ulcerative colitis	5.72e-05	0.000405	CcSEcCtD
Sunitinib—Flushing—Prednisone—ulcerative colitis	5.72e-05	0.000404	CcSEcCtD
Sunitinib—Skin disorder—Hydrocortisone—ulcerative colitis	5.72e-05	0.000404	CcSEcCtD
Sunitinib—Headache—Azathioprine—ulcerative colitis	5.69e-05	0.000402	CcSEcCtD
Sunitinib—Diarrhoea—Mesalazine—ulcerative colitis	5.66e-05	0.0004	CcSEcCtD
Sunitinib—Dry mouth—Triamcinolone—ulcerative colitis	5.65e-05	0.0004	CcSEcCtD
Sunitinib—Angioedema—Dexamethasone—ulcerative colitis	5.63e-05	0.000398	CcSEcCtD
Sunitinib—Angioedema—Betamethasone—ulcerative colitis	5.63e-05	0.000398	CcSEcCtD
Sunitinib—Anorexia—Hydrocortisone—ulcerative colitis	5.61e-05	0.000397	CcSEcCtD
Sunitinib—Angiopathy—Prednisone—ulcerative colitis	5.59e-05	0.000395	CcSEcCtD
Sunitinib—Immune system disorder—Prednisone—ulcerative colitis	5.57e-05	0.000394	CcSEcCtD
Sunitinib—PRPF4—Norethindrone—Hydrocortisone—ulcerative colitis	5.55e-05	0.0178	CbGdCrCtD
Sunitinib—Oedema—Triamcinolone—ulcerative colitis	5.54e-05	0.000392	CcSEcCtD
Sunitinib—Arrhythmia—Prednisone—ulcerative colitis	5.51e-05	0.000389	CcSEcCtD
Sunitinib—Infection—Triamcinolone—ulcerative colitis	5.51e-05	0.000389	CcSEcCtD
Sunitinib—CYP3A4—liver—ulcerative colitis	5.5e-05	0.000532	CbGeAlD
Sunitinib—Infection—Methylprednisolone—ulcerative colitis	5.49e-05	0.000388	CcSEcCtD
Sunitinib—Dizziness—Mesalazine—ulcerative colitis	5.47e-05	0.000387	CcSEcCtD
Sunitinib—Shock—Triamcinolone—ulcerative colitis	5.45e-05	0.000385	CcSEcCtD
Sunitinib—Insomnia—Prednisolone—ulcerative colitis	5.45e-05	0.000385	CcSEcCtD
Sunitinib—Alopecia—Prednisone—ulcerative colitis	5.45e-05	0.000385	CcSEcCtD
Sunitinib—Shock—Methylprednisolone—ulcerative colitis	5.44e-05	0.000385	CcSEcCtD
Sunitinib—Nervous system disorder—Methylprednisolone—ulcerative colitis	5.42e-05	0.000383	CcSEcCtD
Sunitinib—Paraesthesia—Prednisolone—ulcerative colitis	5.41e-05	0.000382	CcSEcCtD
Sunitinib—Mental disorder—Prednisone—ulcerative colitis	5.4e-05	0.000382	CcSEcCtD
Sunitinib—Nausea—Azathioprine—ulcerative colitis	5.4e-05	0.000381	CcSEcCtD
Sunitinib—Skin disorder—Methylprednisolone—ulcerative colitis	5.37e-05	0.00038	CcSEcCtD
Sunitinib—Erythema—Prednisone—ulcerative colitis	5.37e-05	0.000379	CcSEcCtD
Sunitinib—Malnutrition—Prednisone—ulcerative colitis	5.37e-05	0.000379	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	5.36e-05	0.000379	CcSEcCtD
Sunitinib—CSNK1E—Dexamethasone—Hydrocortisone—ulcerative colitis	5.36e-05	0.0171	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Hydrocortisone—ulcerative colitis	5.36e-05	0.0171	CbGdCrCtD
Sunitinib—Convulsion—Dexamethasone—ulcerative colitis	5.34e-05	0.000377	CcSEcCtD
Sunitinib—Convulsion—Betamethasone—ulcerative colitis	5.34e-05	0.000377	CcSEcCtD
Sunitinib—Insomnia—Hydrocortisone—ulcerative colitis	5.32e-05	0.000376	CcSEcCtD
Sunitinib—Hypertension—Betamethasone—ulcerative colitis	5.32e-05	0.000376	CcSEcCtD
Sunitinib—Hypertension—Dexamethasone—ulcerative colitis	5.32e-05	0.000376	CcSEcCtD
Sunitinib—ABCB1—lymphoid tissue—ulcerative colitis	5.29e-05	0.000512	CbGeAlD
Sunitinib—Paraesthesia—Hydrocortisone—ulcerative colitis	5.28e-05	0.000374	CcSEcCtD
Sunitinib—Vomiting—Mesalazine—ulcerative colitis	5.26e-05	0.000372	CcSEcCtD
Sunitinib—Myalgia—Dexamethasone—ulcerative colitis	5.25e-05	0.000371	CcSEcCtD
Sunitinib—Myalgia—Betamethasone—ulcerative colitis	5.25e-05	0.000371	CcSEcCtD
Sunitinib—ABCB1—digestive system—ulcerative colitis	5.22e-05	0.000505	CbGeAlD
Sunitinib—Rash—Mesalazine—ulcerative colitis	5.22e-05	0.000369	CcSEcCtD
Sunitinib—Dermatitis—Mesalazine—ulcerative colitis	5.21e-05	0.000369	CcSEcCtD
Sunitinib—Headache—Mesalazine—ulcerative colitis	5.18e-05	0.000367	CcSEcCtD
Sunitinib—Dyspepsia—Hydrocortisone—ulcerative colitis	5.18e-05	0.000366	CcSEcCtD
Sunitinib—CHEK2—Testosterone Propionate—Hydrocortisone—ulcerative colitis	5.17e-05	0.0165	CbGdCrCtD
Sunitinib—Pain—Prednisolone—ulcerative colitis	5.15e-05	0.000364	CcSEcCtD
Sunitinib—Decreased appetite—Hydrocortisone—ulcerative colitis	5.12e-05	0.000362	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	5.08e-05	0.000359	CcSEcCtD
Sunitinib—Fatigue—Hydrocortisone—ulcerative colitis	5.07e-05	0.000359	CcSEcCtD
Sunitinib—CSNK1E—Betamethasone—Methylprednisolone—ulcerative colitis	5.06e-05	0.0162	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Methylprednisolone—ulcerative colitis	5.06e-05	0.0162	CbGdCrCtD
Sunitinib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	5.05e-05	0.000357	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	5.04e-05	0.000356	CcSEcCtD
Sunitinib—Pain—Hydrocortisone—ulcerative colitis	5.03e-05	0.000356	CcSEcCtD
Sunitinib—Oedema—Dexamethasone—ulcerative colitis	5.03e-05	0.000355	CcSEcCtD
Sunitinib—Oedema—Betamethasone—ulcerative colitis	5.03e-05	0.000355	CcSEcCtD
Sunitinib—Insomnia—Triamcinolone—ulcerative colitis	5.01e-05	0.000354	CcSEcCtD
Sunitinib—Insomnia—Methylprednisolone—ulcerative colitis	5e-05	0.000354	CcSEcCtD
Sunitinib—Infection—Betamethasone—ulcerative colitis	5e-05	0.000353	CcSEcCtD
Sunitinib—Infection—Dexamethasone—ulcerative colitis	5e-05	0.000353	CcSEcCtD
Sunitinib—CSNK1E—Dexamethasone—Betamethasone—ulcerative colitis	4.98e-05	0.0159	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Dexamethasone—ulcerative colitis	4.98e-05	0.0159	CbGdCrCtD
Sunitinib—Paraesthesia—Triamcinolone—ulcerative colitis	4.98e-05	0.000352	CcSEcCtD
Sunitinib—Paraesthesia—Methylprednisolone—ulcerative colitis	4.96e-05	0.000351	CcSEcCtD
Sunitinib—Anaemia—Prednisone—ulcerative colitis	4.96e-05	0.000351	CcSEcCtD
Sunitinib—Shock—Dexamethasone—ulcerative colitis	4.95e-05	0.00035	CcSEcCtD
Sunitinib—Shock—Betamethasone—ulcerative colitis	4.95e-05	0.00035	CcSEcCtD
Sunitinib—Dyspnoea—Triamcinolone—ulcerative colitis	4.94e-05	0.000349	CcSEcCtD
Sunitinib—Nervous system disorder—Betamethasone—ulcerative colitis	4.93e-05	0.000349	CcSEcCtD
Sunitinib—Nervous system disorder—Dexamethasone—ulcerative colitis	4.93e-05	0.000349	CcSEcCtD
Sunitinib—Thrombocytopenia—Betamethasone—ulcerative colitis	4.92e-05	0.000348	CcSEcCtD
Sunitinib—Thrombocytopenia—Dexamethasone—ulcerative colitis	4.92e-05	0.000348	CcSEcCtD
Sunitinib—Nausea—Mesalazine—ulcerative colitis	4.92e-05	0.000348	CcSEcCtD
Sunitinib—Angioedema—Prednisone—ulcerative colitis	4.9e-05	0.000347	CcSEcCtD
Sunitinib—Dyspepsia—Triamcinolone—ulcerative colitis	4.88e-05	0.000345	CcSEcCtD
Sunitinib—Dyspepsia—Methylprednisolone—ulcerative colitis	4.87e-05	0.000344	CcSEcCtD
Sunitinib—CSNK1E—Dexamethasone—Triamcinolone—ulcerative colitis	4.87e-05	0.0155	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Triamcinolone—ulcerative colitis	4.87e-05	0.0155	CbGdCrCtD
Sunitinib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	4.81e-05	0.00034	CcSEcCtD
Sunitinib—Anorexia—Betamethasone—ulcerative colitis	4.79e-05	0.000339	CcSEcCtD
Sunitinib—Anorexia—Dexamethasone—ulcerative colitis	4.79e-05	0.000339	CcSEcCtD
Sunitinib—Fatigue—Triamcinolone—ulcerative colitis	4.78e-05	0.000338	CcSEcCtD
Sunitinib—Fatigue—Methylprednisolone—ulcerative colitis	4.77e-05	0.000337	CcSEcCtD
Sunitinib—Pain—Triamcinolone—ulcerative colitis	4.74e-05	0.000335	CcSEcCtD
Sunitinib—Body temperature increased—Hydrocortisone—ulcerative colitis	4.65e-05	0.000329	CcSEcCtD
Sunitinib—Abdominal pain—Hydrocortisone—ulcerative colitis	4.65e-05	0.000329	CcSEcCtD
Sunitinib—Convulsion—Prednisone—ulcerative colitis	4.65e-05	0.000329	CcSEcCtD
Sunitinib—Hypertension—Prednisone—ulcerative colitis	4.63e-05	0.000327	CcSEcCtD
Sunitinib—CSNK1E—Dexamethasone—Prednisone—ulcerative colitis	4.62e-05	0.0148	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Prednisone—ulcerative colitis	4.62e-05	0.0148	CbGdCrCtD
Sunitinib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	4.58e-05	0.000324	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	4.58e-05	0.000324	CcSEcCtD
Sunitinib—Arthralgia—Prednisone—ulcerative colitis	4.57e-05	0.000323	CcSEcCtD
Sunitinib—Myalgia—Prednisone—ulcerative colitis	4.57e-05	0.000323	CcSEcCtD
Sunitinib—Insomnia—Dexamethasone—ulcerative colitis	4.55e-05	0.000321	CcSEcCtD
Sunitinib—Insomnia—Betamethasone—ulcerative colitis	4.55e-05	0.000321	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	4.54e-05	0.000321	CcSEcCtD
Sunitinib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	4.52e-05	0.00032	CcSEcCtD
Sunitinib—Paraesthesia—Dexamethasone—ulcerative colitis	4.52e-05	0.000319	CcSEcCtD
Sunitinib—Paraesthesia—Betamethasone—ulcerative colitis	4.52e-05	0.000319	CcSEcCtD
Sunitinib—CSNK1E—Betamethasone—Prednisolone—ulcerative colitis	4.51e-05	0.0144	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Prednisolone—ulcerative colitis	4.51e-05	0.0144	CbGdCrCtD
Sunitinib—Hypersensitivity—Prednisolone—ulcerative colitis	4.44e-05	0.000314	CcSEcCtD
Sunitinib—Dyspepsia—Dexamethasone—ulcerative colitis	4.43e-05	0.000313	CcSEcCtD
Sunitinib—Dyspepsia—Betamethasone—ulcerative colitis	4.43e-05	0.000313	CcSEcCtD
Sunitinib—PRPF4—Levonorgestrel—Hydrocortisone—ulcerative colitis	4.42e-05	0.0141	CbGdCrCtD
Sunitinib—Body temperature increased—Triamcinolone—ulcerative colitis	4.38e-05	0.00031	CcSEcCtD
Sunitinib—Oedema—Prednisone—ulcerative colitis	4.38e-05	0.00031	CcSEcCtD
Sunitinib—Abdominal pain—Methylprednisolone—ulcerative colitis	4.37e-05	0.000309	CcSEcCtD
Sunitinib—Decreased appetite—Dexamethasone—ulcerative colitis	4.37e-05	0.000309	CcSEcCtD
Sunitinib—Decreased appetite—Betamethasone—ulcerative colitis	4.37e-05	0.000309	CcSEcCtD
Sunitinib—Infection—Prednisone—ulcerative colitis	4.35e-05	0.000308	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	4.34e-05	0.000307	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	4.34e-05	0.000307	CcSEcCtD
Sunitinib—Hypersensitivity—Hydrocortisone—ulcerative colitis	4.34e-05	0.000307	CcSEcCtD
Sunitinib—Fatigue—Dexamethasone—ulcerative colitis	4.34e-05	0.000306	CcSEcCtD
Sunitinib—Fatigue—Betamethasone—ulcerative colitis	4.34e-05	0.000306	CcSEcCtD
Sunitinib—Shock—Prednisone—ulcerative colitis	4.31e-05	0.000305	CcSEcCtD
Sunitinib—Pain—Dexamethasone—ulcerative colitis	4.3e-05	0.000304	CcSEcCtD
Sunitinib—Pain—Betamethasone—ulcerative colitis	4.3e-05	0.000304	CcSEcCtD
Sunitinib—CHEK2—Danazol—Hydrocortisone—ulcerative colitis	4.3e-05	0.0137	CbGdCrCtD
Sunitinib—Nervous system disorder—Prednisone—ulcerative colitis	4.29e-05	0.000304	CcSEcCtD
Sunitinib—Skin disorder—Prednisone—ulcerative colitis	4.25e-05	0.000301	CcSEcCtD
Sunitinib—Asthenia—Hydrocortisone—ulcerative colitis	4.22e-05	0.000298	CcSEcCtD
Sunitinib—Anorexia—Prednisone—ulcerative colitis	4.17e-05	0.000295	CcSEcCtD
Sunitinib—Pruritus—Hydrocortisone—ulcerative colitis	4.16e-05	0.000294	CcSEcCtD
Sunitinib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	4.11e-05	0.000291	CcSEcCtD
Sunitinib—Gastrointestinal pain—Betamethasone—ulcerative colitis	4.11e-05	0.000291	CcSEcCtD
Sunitinib—Hypersensitivity—Triamcinolone—ulcerative colitis	4.08e-05	0.000289	CcSEcCtD
Sunitinib—Hypersensitivity—Methylprednisolone—ulcerative colitis	4.07e-05	0.000288	CcSEcCtD
Sunitinib—Diarrhoea—Hydrocortisone—ulcerative colitis	4.03e-05	0.000285	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	3.99e-05	0.000282	CcSEcCtD
Sunitinib—Dizziness—Prednisolone—ulcerative colitis	3.98e-05	0.000282	CcSEcCtD
Sunitinib—Asthenia—Triamcinolone—ulcerative colitis	3.98e-05	0.000281	CcSEcCtD
Sunitinib—Body temperature increased—Dexamethasone—ulcerative colitis	3.97e-05	0.000281	CcSEcCtD
Sunitinib—Abdominal pain—Betamethasone—ulcerative colitis	3.97e-05	0.000281	CcSEcCtD
Sunitinib—Body temperature increased—Betamethasone—ulcerative colitis	3.97e-05	0.000281	CcSEcCtD
Sunitinib—Abdominal pain—Dexamethasone—ulcerative colitis	3.97e-05	0.000281	CcSEcCtD
Sunitinib—Asthenia—Methylprednisolone—ulcerative colitis	3.97e-05	0.00028	CcSEcCtD
Sunitinib—Insomnia—Prednisone—ulcerative colitis	3.96e-05	0.00028	CcSEcCtD
Sunitinib—Paraesthesia—Prednisone—ulcerative colitis	3.93e-05	0.000278	CcSEcCtD
Sunitinib—Pruritus—Triamcinolone—ulcerative colitis	3.92e-05	0.000277	CcSEcCtD
Sunitinib—Pruritus—Methylprednisolone—ulcerative colitis	3.91e-05	0.000277	CcSEcCtD
Sunitinib—ABCB1—liver—ulcerative colitis	3.89e-05	0.000377	CbGeAlD
Sunitinib—Dizziness—Hydrocortisone—ulcerative colitis	3.89e-05	0.000275	CcSEcCtD
Sunitinib—CHEK2—Norethindrone—Hydrocortisone—ulcerative colitis	3.87e-05	0.0124	CbGdCrCtD
Sunitinib—Dyspepsia—Prednisone—ulcerative colitis	3.85e-05	0.000272	CcSEcCtD
Sunitinib—Decreased appetite—Prednisone—ulcerative colitis	3.81e-05	0.000269	CcSEcCtD
Sunitinib—Rash—Prednisolone—ulcerative colitis	3.8e-05	0.000269	CcSEcCtD
Sunitinib—Dermatitis—Prednisolone—ulcerative colitis	3.8e-05	0.000268	CcSEcCtD
Sunitinib—Diarrhoea—Methylprednisolone—ulcerative colitis	3.78e-05	0.000267	CcSEcCtD
Sunitinib—Fatigue—Prednisone—ulcerative colitis	3.78e-05	0.000267	CcSEcCtD
Sunitinib—Headache—Prednisolone—ulcerative colitis	3.78e-05	0.000267	CcSEcCtD
Sunitinib—Constipation—Prednisone—ulcerative colitis	3.74e-05	0.000265	CcSEcCtD
Sunitinib—Vomiting—Hydrocortisone—ulcerative colitis	3.74e-05	0.000265	CcSEcCtD
Sunitinib—Rash—Hydrocortisone—ulcerative colitis	3.71e-05	0.000262	CcSEcCtD
Sunitinib—Dermatitis—Hydrocortisone—ulcerative colitis	3.71e-05	0.000262	CcSEcCtD
Sunitinib—CHEK2—Danazol—Prednisone—ulcerative colitis	3.7e-05	0.0118	CbGdCrCtD
Sunitinib—Headache—Hydrocortisone—ulcerative colitis	3.69e-05	0.000261	CcSEcCtD
Sunitinib—Dizziness—Triamcinolone—ulcerative colitis	3.66e-05	0.000259	CcSEcCtD
Sunitinib—Dizziness—Methylprednisolone—ulcerative colitis	3.66e-05	0.000258	CcSEcCtD
Sunitinib—Asthenia—Betamethasone—ulcerative colitis	3.61e-05	0.000255	CcSEcCtD
Sunitinib—Asthenia—Dexamethasone—ulcerative colitis	3.61e-05	0.000255	CcSEcCtD
Sunitinib—Gastrointestinal pain—Prednisone—ulcerative colitis	3.58e-05	0.000253	CcSEcCtD
Sunitinib—Nausea—Prednisolone—ulcerative colitis	3.58e-05	0.000253	CcSEcCtD
Sunitinib—Pruritus—Dexamethasone—ulcerative colitis	3.56e-05	0.000251	CcSEcCtD
Sunitinib—Pruritus—Betamethasone—ulcerative colitis	3.56e-05	0.000251	CcSEcCtD
Sunitinib—Vomiting—Triamcinolone—ulcerative colitis	3.52e-05	0.000249	CcSEcCtD
Sunitinib—Vomiting—Methylprednisolone—ulcerative colitis	3.52e-05	0.000249	CcSEcCtD
Sunitinib—Nausea—Hydrocortisone—ulcerative colitis	3.5e-05	0.000247	CcSEcCtD
Sunitinib—Rash—Triamcinolone—ulcerative colitis	3.49e-05	0.000247	CcSEcCtD
Sunitinib—Dermatitis—Triamcinolone—ulcerative colitis	3.49e-05	0.000247	CcSEcCtD
Sunitinib—Rash—Methylprednisolone—ulcerative colitis	3.49e-05	0.000246	CcSEcCtD
Sunitinib—Dermatitis—Methylprednisolone—ulcerative colitis	3.48e-05	0.000246	CcSEcCtD
Sunitinib—Headache—Triamcinolone—ulcerative colitis	3.47e-05	0.000245	CcSEcCtD
Sunitinib—Headache—Methylprednisolone—ulcerative colitis	3.46e-05	0.000245	CcSEcCtD
Sunitinib—Abdominal pain—Prednisone—ulcerative colitis	3.46e-05	0.000245	CcSEcCtD
Sunitinib—Body temperature increased—Prednisone—ulcerative colitis	3.46e-05	0.000245	CcSEcCtD
Sunitinib—Diarrhoea—Betamethasone—ulcerative colitis	3.44e-05	0.000243	CcSEcCtD
Sunitinib—Diarrhoea—Dexamethasone—ulcerative colitis	3.44e-05	0.000243	CcSEcCtD
Sunitinib—Dizziness—Dexamethasone—ulcerative colitis	3.33e-05	0.000235	CcSEcCtD
Sunitinib—Dizziness—Betamethasone—ulcerative colitis	3.33e-05	0.000235	CcSEcCtD
Sunitinib—Nausea—Triamcinolone—ulcerative colitis	3.29e-05	0.000233	CcSEcCtD
Sunitinib—Nausea—Methylprednisolone—ulcerative colitis	3.28e-05	0.000232	CcSEcCtD
Sunitinib—Hypersensitivity—Prednisone—ulcerative colitis	3.23e-05	0.000228	CcSEcCtD
Sunitinib—Vomiting—Dexamethasone—ulcerative colitis	3.2e-05	0.000226	CcSEcCtD
Sunitinib—Vomiting—Betamethasone—ulcerative colitis	3.2e-05	0.000226	CcSEcCtD
Sunitinib—Rash—Dexamethasone—ulcerative colitis	3.17e-05	0.000224	CcSEcCtD
Sunitinib—Rash—Betamethasone—ulcerative colitis	3.17e-05	0.000224	CcSEcCtD
Sunitinib—Dermatitis—Betamethasone—ulcerative colitis	3.17e-05	0.000224	CcSEcCtD
Sunitinib—Dermatitis—Dexamethasone—ulcerative colitis	3.17e-05	0.000224	CcSEcCtD
Sunitinib—Headache—Dexamethasone—ulcerative colitis	3.15e-05	0.000223	CcSEcCtD
Sunitinib—Headache—Betamethasone—ulcerative colitis	3.15e-05	0.000223	CcSEcCtD
Sunitinib—Asthenia—Prednisone—ulcerative colitis	3.14e-05	0.000222	CcSEcCtD
Sunitinib—Pruritus—Prednisone—ulcerative colitis	3.1e-05	0.000219	CcSEcCtD
Sunitinib—CHEK2—Levonorgestrel—Hydrocortisone—ulcerative colitis	3.08e-05	0.00985	CbGdCrCtD
Sunitinib—Diarrhoea—Prednisone—ulcerative colitis	3e-05	0.000212	CcSEcCtD
Sunitinib—Nausea—Dexamethasone—ulcerative colitis	2.99e-05	0.000211	CcSEcCtD
Sunitinib—Nausea—Betamethasone—ulcerative colitis	2.99e-05	0.000211	CcSEcCtD
Sunitinib—Dizziness—Prednisone—ulcerative colitis	2.9e-05	0.000205	CcSEcCtD
Sunitinib—Vomiting—Prednisone—ulcerative colitis	2.78e-05	0.000197	CcSEcCtD
Sunitinib—Rash—Prednisone—ulcerative colitis	2.76e-05	0.000195	CcSEcCtD
Sunitinib—Dermatitis—Prednisone—ulcerative colitis	2.76e-05	0.000195	CcSEcCtD
Sunitinib—Headache—Prednisone—ulcerative colitis	2.74e-05	0.000194	CcSEcCtD
Sunitinib—Nausea—Prednisone—ulcerative colitis	2.6e-05	0.000184	CcSEcCtD
Sunitinib—PDGFRB—Immune System—NFKB1—ulcerative colitis	1.34e-06	7.24e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—STAT3—ulcerative colitis	1.34e-06	7.23e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TGFB1—ulcerative colitis	1.33e-06	7.18e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—STAT3—ulcerative colitis	1.33e-06	7.18e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MMP9—ulcerative colitis	1.33e-06	7.16e-06	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—IL6—ulcerative colitis	1.33e-06	7.15e-06	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—IL6—ulcerative colitis	1.32e-06	7.14e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—JAK2—ulcerative colitis	1.32e-06	7.14e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TGFB1—ulcerative colitis	1.32e-06	7.12e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL1B—ulcerative colitis	1.32e-06	7.11e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—CD4—ulcerative colitis	1.32e-06	7.11e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL2—ulcerative colitis	1.31e-06	7.09e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—NFKB1—ulcerative colitis	1.31e-06	7.08e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.31e-06	7.08e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—PTGS2—ulcerative colitis	1.31e-06	7.06e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—STAT3—ulcerative colitis	1.31e-06	7.05e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—STAT3—ulcerative colitis	1.3e-06	7.04e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—NFKB1—ulcerative colitis	1.29e-06	6.98e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—NFKB1—ulcerative colitis	1.29e-06	6.94e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—JAK2—ulcerative colitis	1.28e-06	6.93e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—RELA—ulcerative colitis	1.28e-06	6.92e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—CXCL8—ulcerative colitis	1.27e-06	6.87e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—JAK2—ulcerative colitis	1.27e-06	6.85e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—STAT3—ulcerative colitis	1.26e-06	6.78e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—STAT3—ulcerative colitis	1.25e-06	6.74e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—TGFB1—ulcerative colitis	1.25e-06	6.74e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—IL6—ulcerative colitis	1.25e-06	6.73e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—JAK2—ulcerative colitis	1.25e-06	6.72e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—JAK2—ulcerative colitis	1.25e-06	6.72e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—RELA—ulcerative colitis	1.24e-06	6.71e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—STAT3—ulcerative colitis	1.24e-06	6.69e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—IL6—ulcerative colitis	1.24e-06	6.68e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—STAT3—ulcerative colitis	1.24e-06	6.67e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—STAT3—ulcerative colitis	1.24e-06	6.67e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—TGFB1—ulcerative colitis	1.23e-06	6.65e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—NFKB1—ulcerative colitis	1.23e-06	6.64e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—RELA—ulcerative colitis	1.23e-06	6.63e-06	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.23e-06	6.62e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ABCB1—ulcerative colitis	1.22e-06	6.57e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL2—ulcerative colitis	1.22e-06	6.57e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—TGFB1—ulcerative colitis	1.21e-06	6.53e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—STAT3—ulcerative colitis	1.21e-06	6.53e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—STAT3—ulcerative colitis	1.21e-06	6.53e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TGFB1—ulcerative colitis	1.21e-06	6.52e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CXCL8—ulcerative colitis	1.21e-06	6.52e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—RELA—ulcerative colitis	1.21e-06	6.51e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—RELA—ulcerative colitis	1.21e-06	6.51e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—STAT3—ulcerative colitis	1.21e-06	6.51e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—JAK2—ulcerative colitis	1.18e-06	6.38e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PPARG—ulcerative colitis	1.18e-06	6.38e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CALM3—ulcerative colitis	1.18e-06	6.37e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—JAK2—ulcerative colitis	1.18e-06	6.36e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—STAT3—ulcerative colitis	1.18e-06	6.36e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CXCL8—ulcerative colitis	1.17e-06	6.33e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PPARG—ulcerative colitis	1.17e-06	6.32e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TP53—ulcerative colitis	1.17e-06	6.3e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TGFB1—ulcerative colitis	1.16e-06	6.28e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—STAT3—ulcerative colitis	1.16e-06	6.27e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CXCL8—ulcerative colitis	1.16e-06	6.25e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TGFB1—ulcerative colitis	1.16e-06	6.24e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—STAT3—ulcerative colitis	1.16e-06	6.24e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL2—ulcerative colitis	1.15e-06	6.23e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MMP9—ulcerative colitis	1.15e-06	6.22e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—TGFB1—ulcerative colitis	1.15e-06	6.2e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—TGFB1—ulcerative colitis	1.15e-06	6.18e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—RELA—ulcerative colitis	1.15e-06	6.18e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—RELA—ulcerative colitis	1.14e-06	6.16e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—STAT3—ulcerative colitis	1.14e-06	6.16e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—NFKB1—ulcerative colitis	1.14e-06	6.15e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CXCL8—ulcerative colitis	1.14e-06	6.14e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CXCL8—ulcerative colitis	1.14e-06	6.14e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ADCY5—ulcerative colitis	1.14e-06	6.13e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TGFB1—ulcerative colitis	1.12e-06	6.05e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TGFB1—ulcerative colitis	1.12e-06	6.05e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL2—ulcerative colitis	1.12e-06	6.05e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—IL6—ulcerative colitis	1.11e-06	6.02e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—STAT3—ulcerative colitis	1.11e-06	6.01e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL2—ulcerative colitis	1.11e-06	5.97e-06	CbGpPWpGaD
Sunitinib—YES1—Immune System—IL6—ulcerative colitis	1.11e-06	5.97e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—STAT3—ulcerative colitis	1.11e-06	5.96e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TP53—ulcerative colitis	1.1e-06	5.91e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TGFB1—ulcerative colitis	1.09e-06	5.9e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MMP9—ulcerative colitis	1.09e-06	5.89e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—JAK2—ulcerative colitis	1.09e-06	5.88e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL2—ulcerative colitis	1.09e-06	5.86e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL2—ulcerative colitis	1.09e-06	5.86e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TP53—ulcerative colitis	1.09e-06	5.86e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—NFKB1—ulcerative colitis	1.08e-06	5.83e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CXCL8—ulcerative colitis	1.08e-06	5.82e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CXCL8—ulcerative colitis	1.08e-06	5.81e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—STAT3—ulcerative colitis	1.07e-06	5.79e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—IL6—ulcerative colitis	1.07e-06	5.77e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—STAT3—ulcerative colitis	1.07e-06	5.76e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—ALB—ulcerative colitis	1.06e-06	5.73e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—JAK2—ulcerative colitis	1.06e-06	5.73e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MMP9—ulcerative colitis	1.06e-06	5.72e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—TGFB1—ulcerative colitis	1.06e-06	5.71e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—RELA—ulcerative colitis	1.05e-06	5.69e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—ALB—ulcerative colitis	1.05e-06	5.68e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—IL6—ulcerative colitis	1.05e-06	5.66e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—NFKB1—ulcerative colitis	1.05e-06	5.66e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MMP9—ulcerative colitis	1.05e-06	5.65e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—NFKB1—ulcerative colitis	1.04e-06	5.59e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—TGFB1—ulcerative colitis	1.03e-06	5.57e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL2—ulcerative colitis	1.03e-06	5.57e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—RELA—ulcerative colitis	1.03e-06	5.55e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL2—ulcerative colitis	1.03e-06	5.55e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MMP9—ulcerative colitis	1.03e-06	5.55e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MMP9—ulcerative colitis	1.03e-06	5.55e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—JAK2—ulcerative colitis	1.02e-06	5.53e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—STAT3—ulcerative colitis	1.02e-06	5.53e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—STAT3—ulcerative colitis	1.02e-06	5.51e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—JAK2—ulcerative colitis	1.02e-06	5.5e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL6—ulcerative colitis	1.02e-06	5.5e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—NFKB1—ulcerative colitis	1.02e-06	5.49e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—NFKB1—ulcerative colitis	1.02e-06	5.49e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL6—ulcerative colitis	1.01e-06	5.43e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—IL6—ulcerative colitis	1e-06	5.41e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TP53—ulcerative colitis	9.95e-07	5.37e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—TGFB1—ulcerative colitis	9.95e-07	5.37e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—IL6—ulcerative colitis	9.94e-07	5.37e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CXCL8—ulcerative colitis	9.94e-07	5.36e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—RELA—ulcerative colitis	9.92e-07	5.35e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—TGFB1—ulcerative colitis	9.9e-07	5.34e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL6—ulcerative colitis	9.88e-07	5.33e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL6—ulcerative colitis	9.88e-07	5.33e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—RELA—ulcerative colitis	9.87e-07	5.32e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MMP9—ulcerative colitis	9.76e-07	5.27e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MMP9—ulcerative colitis	9.74e-07	5.25e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—STAT3—ulcerative colitis	9.71e-07	5.24e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CXCL8—ulcerative colitis	9.7e-07	5.23e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—NFKB1—ulcerative colitis	9.66e-07	5.21e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—NFKB1—ulcerative colitis	9.63e-07	5.2e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—ulcerative colitis	9.59e-07	5.17e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—ulcerative colitis	9.52e-07	5.14e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL2—ulcerative colitis	9.5e-07	5.13e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TGFB1—ulcerative colitis	9.49e-07	5.12e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—TGFB1—ulcerative colitis	9.46e-07	5.1e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL6—ulcerative colitis	9.45e-07	5.1e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—STAT3—ulcerative colitis	9.43e-07	5.09e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—RELA—ulcerative colitis	9.43e-07	5.09e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—IL6—ulcerative colitis	9.4e-07	5.08e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL6—ulcerative colitis	9.38e-07	5.06e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL6—ulcerative colitis	9.35e-07	5.05e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CXCL8—ulcerative colitis	9.35e-07	5.04e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—STAT3—ulcerative colitis	9.31e-07	5.02e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CXCL8—ulcerative colitis	9.3e-07	5.02e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTGS2—ulcerative colitis	9.3e-07	5.02e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—IL6—ulcerative colitis	9.29e-07	5.01e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL2—ulcerative colitis	9.27e-07	5e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—ulcerative colitis	9.23e-07	4.98e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—ulcerative colitis	9.23e-07	4.98e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTGS2—ulcerative colitis	9.21e-07	4.97e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—STAT3—ulcerative colitis	9.14e-07	4.94e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—STAT3—ulcerative colitis	9.14e-07	4.94e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—IL6—ulcerative colitis	9.12e-07	4.92e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL6—ulcerative colitis	9.11e-07	4.92e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TGFB1—ulcerative colitis	9e-07	4.86e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—ulcerative colitis	9e-07	4.86e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MMP9—ulcerative colitis	8.99e-07	4.85e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL2—ulcerative colitis	8.93e-07	4.82e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NFKB1—ulcerative colitis	8.89e-07	4.8e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CXCL8—ulcerative colitis	8.88e-07	4.79e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL2—ulcerative colitis	8.88e-07	4.79e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL6—ulcerative colitis	8.84e-07	4.77e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL6—ulcerative colitis	8.77e-07	4.74e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MMP9—ulcerative colitis	8.77e-07	4.73e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TGFB1—ulcerative colitis	8.74e-07	4.72e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL6—ulcerative colitis	8.72e-07	4.7e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—STAT3—ulcerative colitis	8.68e-07	4.68e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NFKB1—ulcerative colitis	8.68e-07	4.68e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—IL6—ulcerative colitis	8.66e-07	4.67e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—STAT3—ulcerative colitis	8.66e-07	4.67e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—IL6—ulcerative colitis	8.63e-07	4.66e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL6—ulcerative colitis	8.63e-07	4.66e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TGFB1—ulcerative colitis	8.63e-07	4.66e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ADCY5—ulcerative colitis	8.57e-07	4.62e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL2—ulcerative colitis	8.49e-07	4.58e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TGFB1—ulcerative colitis	8.48e-07	4.57e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TGFB1—ulcerative colitis	8.48e-07	4.57e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PPARG—ulcerative colitis	8.47e-07	4.57e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MMP9—ulcerative colitis	8.45e-07	4.56e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—ulcerative colitis	8.45e-07	4.56e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—ulcerative colitis	8.45e-07	4.56e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—ulcerative colitis	8.45e-07	4.56e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—ulcerative colitis	8.42e-07	4.55e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MMP9—ulcerative colitis	8.41e-07	4.54e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NFKB1—ulcerative colitis	8.36e-07	4.51e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NFKB1—ulcerative colitis	8.32e-07	4.49e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—ulcerative colitis	8.24e-07	4.45e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—ulcerative colitis	8.12e-07	4.38e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	8.08e-07	4.36e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—ulcerative colitis	8.08e-07	4.36e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TGFB1—ulcerative colitis	8.04e-07	4.34e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP9—ulcerative colitis	8.04e-07	4.34e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TGFB1—ulcerative colitis	8.02e-07	4.33e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—STAT3—ulcerative colitis	7.99e-07	4.31e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—ulcerative colitis	7.97e-07	4.3e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NFKB1—ulcerative colitis	7.95e-07	4.29e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—ulcerative colitis	7.81e-07	4.22e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—STAT3—ulcerative colitis	7.8e-07	4.21e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—ulcerative colitis	7.78e-07	4.2e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—ulcerative colitis	7.72e-07	4.17e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ALB—ulcerative colitis	7.61e-07	4.11e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—STAT3—ulcerative colitis	7.52e-07	4.06e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—ulcerative colitis	7.5e-07	4.05e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—STAT3—ulcerative colitis	7.48e-07	4.03e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—ulcerative colitis	7.46e-07	4.02e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—ulcerative colitis	7.41e-07	4e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TGFB1—ulcerative colitis	7.41e-07	4e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CALM3—ulcerative colitis	7.28e-07	3.93e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TGFB1—ulcerative colitis	7.23e-07	3.9e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—ulcerative colitis	7.19e-07	3.88e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—ulcerative colitis	7.15e-07	3.86e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—STAT3—ulcerative colitis	7.15e-07	3.86e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—ulcerative colitis	7.13e-07	3.85e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—ulcerative colitis	7.11e-07	3.83e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—ulcerative colitis	6.98e-07	3.77e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—ulcerative colitis	6.98e-07	3.77e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TGFB1—ulcerative colitis	6.97e-07	3.76e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TGFB1—ulcerative colitis	6.93e-07	3.74e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—ulcerative colitis	6.78e-07	3.66e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—ulcerative colitis	6.66e-07	3.59e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TGFB1—ulcerative colitis	6.62e-07	3.57e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—ulcerative colitis	6.62e-07	3.57e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—ulcerative colitis	6.61e-07	3.56e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—ulcerative colitis	6.59e-07	3.55e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—ulcerative colitis	6.5e-07	3.51e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARG—ulcerative colitis	6.39e-07	3.45e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—ulcerative colitis	6.39e-07	3.45e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—ulcerative colitis	6.39e-07	3.45e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—ulcerative colitis	6.1e-07	3.29e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—ulcerative colitis	6.06e-07	3.27e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—ulcerative colitis	6.05e-07	3.26e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—ulcerative colitis	5.95e-07	3.21e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ALB—ulcerative colitis	5.74e-07	3.1e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—ulcerative colitis	5.74e-07	3.1e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—ulcerative colitis	5.71e-07	3.08e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	5.66e-07	3.05e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—ulcerative colitis	5.58e-07	3.01e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—ulcerative colitis	5.45e-07	2.94e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—ulcerative colitis	5.45e-07	2.94e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	5.28e-07	2.85e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—ulcerative colitis	5.25e-07	2.83e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—ulcerative colitis	5.22e-07	2.82e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—ulcerative colitis	5.03e-07	2.71e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—ulcerative colitis	4.99e-07	2.69e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.94e-07	2.12e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ALB—ulcerative colitis	3.54e-07	1.91e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	3.1e-07	1.67e-06	CbGpPWpGaD
